Information Technology Co-op
Keros Therapeutics
Information Technology Co-op
Keros Therapeutics
Develops TGF-ß signaling-modulating therapeutics
At Keros, our mission is to deliver significant clinical benefit to a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. With a focus on developing differentiated product candidates that are designed to alter TGF-β signaling, we aim to target the pathways critical for the growth, repair and maintenance of blood cells and a number of tissues, including bone, skeletal muscle, adipose and heart tissue. We believe our product candidates have the potential to unlock the full therapeutic benefits of modulating the TGF-β superfamily and provide disease-modifying benefit to patients.
Job Summary
Keros Therapeutics is seeking a motivated and technically curious IT Operations Co-op to join our Information Technology team. This position provides an exceptional opportunity for a 3rd or 4th year college student to gain hands-on experience supporting enterprise technology operations within a fast-paced biotechnology environment.
The co-op will work alongside experienced IT professionals to support end-user technology, device management, cybersecurity initiatives, cloud platforms, collaboration tools, and day-to-day IT operations. The student will develop practical skills in enterprise IT while contributing to projects that directly support research, clinical, and corporate business functions.
This role is ideal for students interested in Infrastructure & Operations, Cybersecurity, Cloud Technologies, Desktop Engineering, Systems Administration, or IT Service Management. Responsibilities align with the operational support functions utilized within Keros IT, including endpoint support, user onboarding, documentation, training, and operational improvement initiatives.
Primary Responsibilities
Core Competencies (Required Skills)
Customer Service Focus
Problem Solving
Learning Agility
Teamwork & Collaboration
Communication Skills
Attention to Detail
Accountability
Preferred Skills
Education Requirements
This pay range represents the base hourly rate or base annual full-time salary for all positions in the job grade within which this position falls. The actual base salary offer will depend on a variety of factors including experience, education, and other relevant factors.
Our Diversity, Equity & Inclusion Mission Statement:Keros is an inclusive company. We believe that diversity drives innovation. We continue to build an inclusive culture that encourages, supports, and celebrates the diverse voices of our employees. As such, Keros takes a holistic approach in mentoring, coaching, and developing all of our Keros team members.
Keros Therapeutics is an Equal Opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected veteran status, or any other characteristic protected by applicable federal, state, or local law.
Recruitment & Staffing Agencies:
Keros Therapeutics does not accept unsolicited resumes from any source other than the candidate directly. Any unsolicited submission by an agency to Keros is prohibited. Any resume submitted by an agency without a signed contract or expressed consent by a member of the Keros Therapeutics Human Resources Department, will be considered property of Keros Therapeutics, and no fee shall be owed with respect thereto.
Potential base pay range 28 - 32 USD
Develops TGF-ß signaling-modulating therapeutics
Keros Therapeutics focuses on developing therapies that target the transforming growth factor-beta (TGF-ß) signaling pathway to treat diseases linked to its dysfunction. Its products aim to modulate TGF-ß signaling to influence cellular growth and repair, with the goal of altering disease progression and providing disease-modifying benefits, especially in blood cells and tissues. The company advances therapeutics through research and development, with commercialization as its end goal once therapies are approved for patients. What sets Keros apart is its specialized expertise in TGF-ß biology and its emphasis on creating drugs that directly modulate this signaling network to produce meaningful clinical outcomes. The overall goal is to bring therapies to market that improve patient outcomes by correcting or adjusting TGF-ß-related signaling in relevant diseases.
Explore more opportunities at Keros Therapeutics